Compounds > flavone
Page last updated: 2024-08-21

flavone and Breast Cancer

flavone has been researched along with Breast Cancer in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Muftuoglu, Y; Mustata, G1
Bönisch, H; Haenisch, B; Mayer, R; Müller, CE; Müller, H; Pajeva, IK; Pick, A; Weigt, M; Wiese, M1
Amato, E; Bankemper, T; Do, T; Kidney, R; Ma, L; Merino, EJ; Onate, A; Paula, S; Thowfeik, FS1
Ahmad, I1
Chong, C; Li, B; Pan, H; Song, Y; Wang, J; Wei, M; Wei, Y; Xie, M; Yang, C; Yang, G; Yu, L; Zhang, J; Zhang, Z; Zhao, R1
Badana, A; Bevara, GB; Koteshwaramma, KL; Kumari, S; Malla, RR; Naveen Kumar, AD1
Abarzua, S; Briese, V; Chrobak, M; Dian, D; Friese, K; Jeschke, U; Kuhn, C; Kupka, MS; Makrigiannakis, A; Piechulla, B; Richter, D; Schulze, S; Vrekoussis, T; Weissenbacher, T1
Chai, R; Fu, H; Li, G; Liu, T; Ma, L; Yang, B; Zhang, Q; Zheng, Z; Zhu, W1
Chang, CY; Chen, TH; Lee, KR; Lin, CH; Lin, HJ; Wan, L1
Chai, R; Li, F; Li, G; Liu, T; Liu, Z; Ma, L; Song, T; Yang, B; Zheng, Z; Zhu, W1

Other Studies

10 other study(ies) available for flavone and Breast Cancer

ArticleYear
Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19).
    Bioorganic & medicinal chemistry letters, 2010, May-15, Volume: 20, Issue:10

    Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Computer Simulation; Drug Design; Female; Humans; Models, Chemical; Models, Molecular; Structure-Activity Relationship

2010
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
    Bioorganic & medicinal chemistry, 2011, Mar-15, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Hydrogen Bonding; Models, Molecular; Neoplasm Proteins; Quantitative Structure-Activity Relationship

2011
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.
    Bioorganic & medicinal chemistry, 2014, Jan-01, Volume: 22, Issue:1

    Topics: Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Isoflavones

2014
Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.
    European journal of medicinal chemistry, 2015, Sep-18, Volume: 102

    Topics: Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Estrogens; Female; Humans; Molecular Conformation; Structure-Activity Relationship

2015
Design and synthesis of novel Flavone-based histone deacetylase inhibitors antagonizing activation of STAT3 in breast cancer.
    European journal of medicinal chemistry, 2020, Nov-15, Volume: 206

    Topics: Acetylation; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dose-Response Relationship, Drug; Drug Design; Flavones; G1 Phase Cell Cycle Checkpoints; Histone Deacetylase Inhibitors; Histones; Humans; S Phase Cell Cycle Checkpoints; Signal Transduction; STAT3 Transcription Factor; Tubulin

2020
C-glycosyl flavone from
    The Indian journal of medical research, 2018, Volume: 147, Issue:2

    Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclin-Dependent Kinase 6; Drimia; Female; Flavones; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Neovascularization, Pathologic

2018
Effects of phytoestrogen extracts isolated from pumpkin seeds on estradiol production and ER/PR expression in breast cancer and trophoblast tumor cells.
    Nutrition and cancer, 2013, Volume: 65, Issue:5

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cucurbita; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Flavones; Humans; Immunohistochemistry; Lignans; MCF-7 Cells; Phytoestrogens; Plant Extracts; Receptors, Progesterone; Seeds; Trophoblastic Neoplasms; Up-Regulation

2013
Flavone inhibits nitric oxide synthase (NOS) activity, nitric oxide production and protein S-nitrosylation in breast cancer cells.
    Biochemical and biophysical research communications, 2015, Mar-13, Volume: 458, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Female; Flavones; Humans; Nitric Oxide; Nitric Oxide Synthase; Proteins

2015
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway.
    BMC cancer, 2015, Dec-16, Volume: 15

    Topics: Antineoplastic Agents, Phytogenic; Apigenin; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Flavones; Flow Cytometry; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Luteolin; Proto-Oncogene Proteins c-akt; Real-Time Polymerase Chain Reaction; Signal Transduction

2015
Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
    In vitro cellular & developmental biology. Animal, 2016, Volume: 52, Issue:5

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Flavones; GTPase-Activating Proteins; Humans; MCF-7 Cells; Reactive Oxygen Species; rhoA GTP-Binding Protein; Signal Transduction; Tumor Suppressor Proteins; Up-Regulation

2016